Oncovision

Oncovision is a private, commercial-stage company specializing in dedicated molecular imaging systems for oncology and neurology. Its core technology platform leverages nuclear medicine techniques to create compact, high-precision imaging devices like the Mammi breast PET and Sentinella intra-operative gamma camera. The company has a global commercial footprint, selling in over 30 markets, and is strategically expanding into neurological diagnostics with its new Mindview business line and CareMiBrain system. Backed by public investment entities like CDTI Innvierte, Oncovision aims to become an international benchmark in specialized medical imaging.

Specialized molecular imaging devices based on nuclear medicine techniques, including dedicated high-resolution PET scanners for specific organs (breast, brain) and hybrid intra-operative gamma cameras fused with optical vision.

Oncovision competes with giants like GE HealthCare, Siemens, and Philips in medical imaging, but differentiates through organ-specific, high-resolution systems. In neurology, it faces competition from other PET manufacturers and emerging blood-based biomarker tests. Its niche strategy focuses on clinical areas underserved by general-purpose scanners.